» Authors » Asad E Patanwala

Asad E Patanwala

Explore the profile of Asad E Patanwala including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 184
Citations 2066
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jamshidi M, Jones C, Langford A, Patanwala A, Liu C, Harris I, et al.
CNS Drugs . 2025 Mar; 39(4):345-360. PMID: 40057907
Background: Opioids are prescribed for postsurgical pain management, but a balance between achieving adequate pain control and minimising opioid-related harm is required. This study aimed to investigate the effectiveness of...
2.
Barletta J, Palmieri T, Toomey S, Alshamsi F, Stearns R, Patanwala A, et al.
Crit Care Med . 2025 Feb; 53(2):e490-e500. PMID: 39982186
Rationale: Predicted increases in heat-related weather phenomena will result in increasing heat exposures and heat injuries, like heat stroke. Prompt recognition, early intervention, and evidence-based management are necessary to optimize...
3.
Barletta J, Palmieri T, Toomey S, Alshamsi F, Stearns R, Patanwala A, et al.
Crit Care Med . 2025 Feb; 53(2):e483-e489. PMID: 39982185
No abstract available.
4.
Young S, Liu S, Patanwala A, Naylor J, Stevens J, Penm J
Anesth Analg . 2025 Jan; PMID: 39874194
Tapering opioids is an effective strategy to reduce the risks associated with long-term opioid therapy. However, patients' experience with tapering can influence the success of this treatment. Understanding patients' experiences...
5.
Patanwala A, Nix D, Hills T, Erstad B
Clin Infect Dis . 2024 Dec; PMID: 39657005
Background: Cefepime and piperacillin-tazobactam are commonly used broad-spectrum antibiotics used to treat patients with potential gram-negative bacterial sepsis. Piperacillin-tazobactam has been shown to be associated with acute kidney injury (AKI)....
6.
Patanwala A, Flannery A, Mehta H, Hills T, McArthur C, Erstad B
Chest . 2024 Oct; PMID: 39426720
Background: Albumin infusions may be renally protective or harmful in patients with septic shock who have kidney impairment. This can affect the need for renal replacement therapy (RRT) and in-hospital...
7.
Patanwala A, Xiao X, Hills T, Higgins A, McArthur C, Alexander G, et al.
Crit Care Med . 2024 Oct; 53(1):e29-e41. PMID: 39365115
Objectives: COVID-19 treatment guidelines recommend baricitinib or tocilizumab for the management of hospitalized patients with COVID-19. We compared the effectiveness of baricitinib vs. tocilizumab on mortality and clinical outcomes among...
8.
Patanwala A, Abu Sardaneh A, Alffenaar J, Choo C, Dey A, Duffy E, et al.
Ann Pharmacother . 2024 Aug; 59(4):311-318. PMID: 39192570
Background: There is little known about antibiotic de-escalation (ADE) practices in the intensive care unit (ICU). Objective: The objective was to determine the proportion of patients who received ADE within...
9.
Appay M, Lai J, Hay J, Calvisi C, Wills G, Kharadi S, et al.
J Thromb Thrombolysis . 2024 Aug; 58(1):109-119. PMID: 39190243
Enoxaparin is dosed according to actual body weight in treatment of arterial and venous thrombosis. Due to its hydrophilic nature, it distributes according to lean body mass which may be...
10.
Francis M, Francis P, Makeham M, Baysari M, Patanwala A, Penm J
Health Inf Manag . 2024 Aug; :18333583241270215. PMID: 39183671
National Personal Health Records (PHRs) have been proposed to improve the transfer of medication-related information during transition of care. To evaluate the concordance between the medications captured in the Australian...